Amy S. Darefsky, Joseph T. King Jr. and Robert Dubrow Adult glioblastoma multiforme survival in the temozolomide era: A population-based analysis of Surveillance, Epidemiology, and End Results registries Cancer 118
Version of Record online: 31 AUG 2011 | DOI: 10.1002/cncr.26494
In the United States, there has been a modest, but meaningful, progressive survival improvement among adult glioblastoma multiform patients diagnosed at all ages except 80+ years, starting with cases diagnosed in 1999-2001 and continuing through cases diagnosed in 2005-2007. This improvement coincided with the progressive, widespread adoption of temozolomide for glioblastoma treatment that also started in 1999.
Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf
Required = Required Field